Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Metastases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06117696
What this trial is testing

Optimizing the Announcement of Advanced or Metastatic Prostate Cancer Using Animated Videos (CartDiag PROSTATE)

Who this might be right for
Prostate Cancer
Direction Centrale du Service de Santé des Armées 90
Testing effectiveness (Phase 2)Study completedNCT00299741
What this trial is testing

Study of SU11248 in Men With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Massachusetts General Hospital 36
Large-scale testing (Phase 3)Study completedNCT00554229
What this trial is testing

A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Hormone Resistant Prostate Cancer With Bone Metastases

Who this might be right for
Prostate Cancer
AstraZeneca 896
Testing effectiveness (Phase 2)Study completedNCT02097303
What this trial is testing

Open Label Phase Two Trial of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Symptomatic Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Bone Metastasis

Who this might be right for
Prostate Cancer
Carolina Research Professionals, LLC 36
Large-scale testing (Phase 3)Study completedNCT00079001
What this trial is testing

Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases

Who this might be right for
Metastatic CancerProstate Cancer
Alliance for Clinical Trials in Oncology 645
Testing effectiveness (Phase 2)Study completedNCT03204812
What this trial is testing

Durvalumab and Tremelimumab in Treating Chemotherapy Naive Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneProstate Adenocarcinoma+3 more
M.D. Anderson Cancer Center 31
Post-approval studies (Phase 4)Not Yet RecruitingNCT07308002
What this trial is testing

Intermittent vs Daily Tamsulosin for LUTS/BPH

Who this might be right for
Lower Urinary Tract SymptomsProstate Obstruction
Mansoura University 288
Not applicableUnknownNCT04507698
What this trial is testing

INTERVAL - Intense Exercise Trial for Men With Metastatic Castrate-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Guy's and St Thomas' NHS Foundation Trust 80
Testing effectiveness (Phase 2)Study completedNCT01541007
What this trial is testing

A Study Looking at Novel Scheduling of Cabazitaxel for Patients With Metastatic Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Jeffrey Yachnin M.D., PhD. 100
Early research (Phase 1)Looking for participantsNCT06458712
What this trial is testing

Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies

Who this might be right for
Advanced Cancers (Breast, Ovarian, mCRPC, Pancreatic Ductal Adenocarcinoma (PDAC), Brain Mets) With Specific Mutations (Homologous Recombination Deficiency)
Duke Street Bio Ltd 180
Testing effectiveness (Phase 2)WithdrawnNCT02621190
What this trial is testing

Cabazitaxel in mCRPC Patients With AR-V7 Positive CTCs

Who this might be right for
Prostatic Neoplasms
Erasmus Medical Center
Testing effectiveness (Phase 2)Study completedNCT00104650
What this trial is testing

Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) Bisphosphonates

Who this might be right for
Bone Metastases in Men With Hormone-Refractory Prostate CancerBone Metastases in Subjects With Advanced Breast CancerBone Metastases in Subjects With Advanced Cancer or Multiple Myeloma
Amgen 111
Large-scale testing (Phase 3)Study completedNCT00321620
What this trial is testing

Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate Cancer

Who this might be right for
Bone Metastases
Amgen 1,904
Testing effectiveness (Phase 2)Study completedNCT00877669
What this trial is testing

Efficacy Study of HoLEP and TURP on LUTS Secondary to BPH

Who this might be right for
Lower Urinary Tract SymptomsBenign Prostatic Hyperplasia
Samsung Medical Center 313
Large-scale testing (Phase 3)UnknownNCT00294151
What this trial is testing

Potential Vertebroplasty Use in the Treatment of Vertebral Metastasis From Breast and Prostate Cancer

Who this might be right for
Breast CancerProstate CancerVertebral Metastasis+1 more
McGill University Health Centre/Research Institute of the McGill University Health Centre 30
Not applicableUnknownNCT03177551
What this trial is testing

Predictive Nomogram of CRPC

Who this might be right for
Castration-resistant Prostate CancerMetastatic Cancer
Tianjin Medical University Second Hospital 300
Not applicableStudy completedNCT03644303
What this trial is testing

Targeted Radiotherapy in Androgen-suppressed Prostate Cancer Patients.

Who this might be right for
Prostate CancerMetastasisToxicity Due to Radiotherapy+1 more
Royal Marsden NHS Foundation Trust 86
Not applicableApproved For MarketingNCT04100694
What this trial is testing

Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor

Who this might be right for
NRG1 FusionPancreatic CancerNon Small Cell Lung Cancer+8 more
Merus B.V.
Not applicableLooking for participantsNCT06700057
What this trial is testing

Clinical and Dosimetric Study of Patients Treated With 177Lu-PSMA-617 for Prostate Cancer.

Who this might be right for
Prostate CancerMetastasis
Institut Bergonié 50
Large-scale testing (Phase 3)Ended earlyNCT02057666
What this trial is testing

Study Of Tasquinimod In Asian Chemo-Naïve Patients With Metastatic Castrate-Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Ipsen 146
Next Page